×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SONN – sonnet biotherapeutics holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SONN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
04:30 pm
sonn
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
High
Report
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
12/2
09:17 am
sonn
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
High
Report
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
11/18
07:06 pm
sonn
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting [Yahoo! Finance]
Medium
Report
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting [Yahoo! Finance]
11/18
09:00 am
sonn
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
Medium
Report
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
10/15
10:03 am
sonn
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
High
Report
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
9/19
09:36 am
sonn
Sonnet to Present at the MedInvest Biotech & Pharma Conference [Yahoo! Finance]
Low
Report
Sonnet to Present at the MedInvest Biotech & Pharma Conference [Yahoo! Finance]
9/19
09:00 am
sonn
Sonnet to Present at the MedInvest Biotech & Pharma Conference
High
Report
Sonnet to Present at the MedInvest Biotech & Pharma Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/4
05:15 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Kenney Richard T
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Kenney Richard T
12/3
09:15 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: MCANDREW STEPHEN J
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: MCANDREW STEPHEN J
12/3
09:13 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Rao Raghu
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Rao Raghu
12/3
09:13 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Dyrness Albert D.
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Dyrness Albert D.
12/3
09:13 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Cini John K.
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Cini John K.
12/3
09:13 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: McNeill Lori
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: McNeill Lori
12/3
09:13 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Dexter Susan
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Dexter Susan
12/3
09:13 pm
sonn
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Bhatt Nailesh
Neutral
Report
Form 4 Sonnet BioTherapeutics For: Dec 02 Filed by: Bhatt Nailesh
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
4/2
RELIEF THERAPEUTICS Holding SA Announces the Closing of its Share Exchange Agreement with Sonnet BioTherapeutics, Inc. for the Divestment of its wholly-owned Subsidiary Relief Therapeutics SA
-32.7%
4/22 Form 10-K/A Sonnet BioTherapeutics For: Dec 31 -11.7%
4/20 Form 8-K Sonnet BioTherapeutics For: Apr 16 -5.7%
4/10 Form SC 13G Sonnet BioTherapeutics Filed by: Altium Capital Management LP -3.3%
4/22 Form 10-K/A Sonnet BioTherapeutics For: Dec 31 -11.7%
4/20 Form 8-K Sonnet BioTherapeutics For: Apr 16 -5.7%
4/10 Form SC 13G Sonnet BioTherapeutics Filed by: Altium Capital Management LP -3.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: